Transform Drug Development with Certara’s Medical Writing Expertise Blog Post
The cost of developing a single drug exceeds $2.6 billion, and the demand for life-saving treatments has never been greater. Certara is here to empower industry leaders like you to reimagine the role of medical writing in accelerating drug development timelines.
Unleashing the Power of Patents: Competitive Analysis in Material Science [Korean webinar] Blog Post
Date: Wednesday, April 16, 2025 Time: 3pm – 4pm, Korea time Solutions: Discovery Services: Drug Development Services Products: Chemaxon Overview This webinar is available only in Korean. In today’s fast-paced...
Protect Confidential Information in Investigational Drug Submissions Blog Post
Honz Slipka March 20, 2025 Health regulatory agencies require pharmaceutical companies to protect study participants’ personal information (PI) within regulatory drug submissions. In addition, pharmaceutical organizations should avoid disclosing company-related...
Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study Blog Post
Publication: The Lancet HIV Objective The IMPAACT 2017/MOCHA study, a phase 1/2 multicenter trial across five countries, assessed the safety, antiviral activity, and pharmacokinetics of long-acting injectable cabotegravir and rilpivirine... Certara & A2Healthcare accelerate Model-informed Drug Development (MIDD) adoption in Japan Blog Post
This new partnership provides Japanese biopharma companies greater access to the latest biosimulation and regulatory solutions to accelerate drug development. RADNOR, PA – March 18, 2025 – Certara, Inc. (Nasdaq:...
Phoenix Hosted: Cloud-Based PK/PD Software for Smarter, Faster Research Blog Post
In this on demand webinar, you’ll discover why Phoenix Hosted is the ideal solution for R&D companies of all sizes.
FDA Requirements for Providing Datasets for Nonclinical Studies in SEND Format Blog Post
Peggy Zorn March 19, 2025 The CDISC Standard for the Exchange of Nonclinical Data (SEND) provides the structure and implementation rules for submitting computer-readable datasets to regulatory agencies. SEND is...
